Development of cross-protective influenza A vaccines based on cellular responses
Seasonal influenza vaccines provide protection against matching influenza A virus (IAV) strains mainly through the induction of neutralizing serum IgG antibodies.However, these antibodies fail to confer a protective effect against mismatched IAV.This lack of efficacy against heterologous influenza strains has spurred the vaccine development communi